Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Oncotarget|February 9, 2018
Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomasTomotaka Shimura, Yuichiro Tada, Hideaki Hirai, et al.
Virchows Archiv : an International Journal of Pathology|February 28, 2020
The clinicopathological significance of the adipophilin and fatty acid synthase expression in salivary duct carcinomaHideaki Hirai, Yuichiro Tada, Masato Nakaguro, et al.
Frontiers in Surgery|December 1, 2022
Head and neck small-cell carcinoma: A multicenter study of 39 cases from 10 institutionsHiroshi Matsuyama, Yushi Ueki, Isaku Okamoto, et al.
Frontiers in Oncology|February 21, 2022
The Role of the EZH2 and H3K27me3 Expression as a Predictor of Clinical Outcomes in Salivary Duct Carcinoma Patients: A Large-Series Study With Emphasis on the Relevance to the Combined Androgen Blockade and HER2-Targeted TherapyNatsuki Saigusa, Hideaki Hirai, Yuichiro Tada, et al.
Oral Oncology|April 19, 2025
The impact of HER2-Low expression in salivary duct carcinoma: Clinicopathologic features, survival outcomes, and association with androgen receptor-targeted therapySatoshi Kano, Daisuke Kawakita, Yoshitaka Honma, et al.
NPJ Precision Oncology|November 5, 2022
Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profilingShinji Kohsaka, Yuichiro Tada, Mizuo Ando, et al.
Therapeutic Advances in Medical Oncology|September 12, 2022
Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinomaDaisuke Kawakita, Toshitaka Nagao, Hideaki Takahashi, et al.
Frontiers in Immunology|August 13, 2024
Clinical, genomic and immune microenvironmental determinants of nivolumab response in head and neck squamous cell carcinomaTakahiro Tsujikawa, Kazuchika Ohno, Kei-Ichi Morita, et al.
BMC Medicine|April 16, 2026
Development of a novel prognostic assessment tool for recurrent respiratory papillomatosisSatoshi Yamada, Taro Ikegami, Takahiro Fukuhara, et al.
Pageof 6